Royer Biomedical

RBI Wins FDA Approval to Progress Human Testing
Nov 28, 2012
Royer Biomedical(RBI)wins FDA approval to progress human testing of AppliGel-G(Gentamicin)in management of diabetic foot ulcers(DFU). The patented proprietary dissolvable non-immunogenic polymer drug delivery system platform has ...

Tags: Royer Biomedical, AppliGel-G, diabetic foot ulcers